An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1095 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An observational study to investigate the efficacy, safety, tolerability and the effect on quality of life of Telmisartan (Micardis) and Telmisartan with HCTZ (Micardis Plus) in patients with hypertension

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT00659607

Hypertension

COMPLETED

Micardis® in Patients With Essential Hypertension

NCT02187705

Hypertension

COMPLETED

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491

Hypertension

COMPLETED PHASE3

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422

Hypertension

COMPLETED PHASE3

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

NCT02242370

Hypertension

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

telmisartan/telmisartan + HCTZ (Hydrochlorothiazide)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Ability to provide written/verbal informed consent in accordance with GCP (Good Clinical Practice) and local legislation
2. Patients aged 18 \~ under 80
3. Hypertension as described below:

* Newly diagnosed patients with hypertension
* Patients with current antihypertensive therapy

Exclusion Criteria

1. Female subjects who are breastfeeding, pregnant or who plan to be pregnant during the study
2. Known or suspected secondary hypertension(e.g. pheochromocytoma)
3. Patients who have been treated with telmisartan prior to the acquisition of informed consent (including verbal informed consent)

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No